| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/25/2009 | WO2009077908A1 Colloidal particle comprising multivalent cyclic anions |
| 06/25/2009 | WO2009077769A2 Carrier |
| 06/25/2009 | WO2009077749A1 Formulations comprising exine shells |
| 06/25/2009 | WO2009077732A2 Slow release compositions |
| 06/25/2009 | WO2009077693A2 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent |
| 06/25/2009 | WO2009077671A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | WO2009077670A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/25/2009 | WO2009077599A2 Nanospheres with external surface of noble metal |
| 06/25/2009 | WO2009077592A1 Pharmaceutical dosage form comprising a liquid or flowable core composition |
| 06/25/2009 | WO2009077573A2 Suspension comprising non-micronized ezetimibe micro-particles |
| 06/25/2009 | WO2009077345A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 06/25/2009 | WO2009077147A2 Pharmaceutical compositions |
| 06/25/2009 | WO2009076983A2 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof |
| 06/25/2009 | WO2009076764A1 Misuse preventative, controlled release formulation |
| 06/25/2009 | WO2009076754A1 Single layered controlled release therapeutic system |
| 06/25/2009 | WO2009076742A1 Effervescent dietary composition for enhancing delivery of dietary ingredients |
| 06/25/2009 | WO2009061372A9 Systems and methods for creating multi-phase entities, including particles and/or fluids |
| 06/25/2009 | WO2009060064A3 Pharmaceutical formulations for the oral administration of ppi |
| 06/25/2009 | WO2009057975A3 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient |
| 06/25/2009 | WO2009053601A3 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 06/25/2009 | WO2009051022A3 Matrix-type pharmaceutical solid preparation |
| 06/25/2009 | WO2009050726A3 Compositions and methods for improved delivery of bupropion |
| 06/25/2009 | WO2009050403A3 Patch with hydrophilic adhesive |
| 06/25/2009 | WO2009047434A9 Use of carriers as preservatives and pharmaceutical composition containing same |
| 06/25/2009 | WO2009046299A3 Implantable drug depot for intrathecal drug delivery system for pain management |
| 06/25/2009 | WO2009032270A3 A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer |
| 06/25/2009 | WO2009032267A3 Contact lens based bioactive agent delivery system |
| 06/25/2009 | WO2009015286A3 Technology for the preparation of microparticles |
| 06/25/2009 | WO2008137826A3 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 06/25/2009 | WO2008110872A3 Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
| 06/25/2009 | WO2008110374A3 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 06/25/2009 | WO2008103431A3 Dnai - liposomes |
| 06/25/2009 | WO2008089087A3 Tablet-in-tablet compositions |
| 06/25/2009 | WO2008065506A3 Pharmaceutical compositions comprising nanoparticles comprising enteric polymers and casein |
| 06/25/2009 | WO2008063279A3 A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof |
| 06/25/2009 | US20090163895 Implantable device for controlled, extended delivery of parathyroid hormone |
| 06/25/2009 | US20090163894 Medical or veterinary digestive tract utilization systems and methods |
| 06/25/2009 | US20090163887 Odor control cellulose granules with quinone compounds |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163550 Retinoid-containing sustained release intraocular implants and related methods |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163436 Methods for delivery of nucleic acids |
| 06/25/2009 | US20090162451 Multilayer pellets containing water-soluble core, antagonist layer comprising naltrexone HCl coating, cationic sequestering polymer layer, agonist layer comprising morphine sulfate, and osmotic pressure regulating agent layer comprising sodium chloride |
| 06/25/2009 | US20090162450 Multilayer pellets containing water-soluble core, antagonist layer comprising naltrexone HCl coating, cationic sequestering polymer layer, agonist layer comprising morphine sulfate, and osmotic pressure regulating agent layer comprising sodium chloride |
| 06/25/2009 | US20090162449 Stable oral benzimidazole compositions and process of preparation thereof |
| 06/25/2009 | US20090162448 Metal Carbonate Particles and Methods of Making Thereof |
| 06/25/2009 | US20090162447 Spherically Shaped Substances |
| 06/25/2009 | US20090162446 Absorbent article having a stable skin care composition |
| 06/25/2009 | US20090162445 bone repair; containing demineralized bone fragments and homogenized connective tissues; used in many different forms |
| 06/25/2009 | US20090162444 Raloxifene composition |
| 06/25/2009 | US20090162443 Compositions and methods for reducing or preventing water loss from the skin |
| 06/25/2009 | US20090162442 Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin |
| 06/25/2009 | US20090162441 Pulmonary delivery in treating disorders of the central nervous system |
| 06/25/2009 | US20090162440 Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof |
| 06/25/2009 | US20090162438 Compositions and methods for joining non-conjoined lumens |
| 06/25/2009 | US20090162437 Modified self-assembling peptides |
| 06/25/2009 | US20090162436 Compositions and methods for repair of tissues |
| 06/25/2009 | US20090162435 Manufacture of tablet |
| 06/25/2009 | US20090162434 Mesalazine tablet |
| 06/25/2009 | US20090162433 Method of treatment |
| 06/25/2009 | US20090162432 Stable laquinimod preparations |
| 06/25/2009 | US20090162431 Sustained release formulations containing acetaminophen and tramadol |
| 06/25/2009 | US20090162430 Gelatin Capsule With Extra Cap for Combined Therapies |
| 06/25/2009 | US20090162429 Slow-Release Composition, Method for the Preparation Thereof, and Use Thereof |
| 06/25/2009 | US20090162428 Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162426 Use of a Compound with RANKL Activity |
| 06/25/2009 | US20090162425 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents |
| 06/25/2009 | US20090162424 Compositions and methods for making and using multifunctional polymerized liposomes |
| 06/25/2009 | US20090162423 Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers |
| 06/25/2009 | US20090162422 Single-domain brain-targeting antibody fragments derived from LLAMA antibodies |
| 06/25/2009 | US20090162421 Drugs as well as their production and use in the treatment of pain-associated neuropathies |
| 06/25/2009 | US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids |
| 06/25/2009 | US20090162418 Indicia-bearing package for delivery systems for managing release of flavors in an edible composition |
| 06/25/2009 | US20090162413 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 06/25/2009 | US20090162412 Implantable polymeric device for sustained release of dopamine agonist |
| 06/25/2009 | US20090162411 Encapsulated kidney tissue |
| 06/25/2009 | US20090162408 Compositions containing cationically surface-modified microparticulate carrier for benefit agents |
| 06/25/2009 | US20090162407 Process for preparing microparticles having a low residual solvent volume |
| 06/25/2009 | US20090162406 Wound healing with zeolite-based hemostatic devices |
| 06/25/2009 | US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 06/25/2009 | US20090162339 drug delivery of an enzyme such as erythromycin esterase or beta-lactamase capable of deactivating a beta -lactam, macrolide, or quinolone antibiotic; reducing the concentration of an antibiotic in the colon; ulcerative colitis or Crohn's disease |
| 06/25/2009 | US20090162322 Oral administration form comprising probiotic bacteria |
| 06/25/2009 | US20090162300 Buccal, polar and non-polar spray containing alprazolam |
| 06/25/2009 | US20090162299 Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer |
| 06/25/2009 | US20090162298 Buccal, polar and non-polar spray containing sumatriptan |
| 06/25/2009 | US20090162297 Buccal, polar and non-polar spray containing ondansetron |
| 06/25/2009 | US20090162296 Approach to treat intraocular hypertension |
| 06/25/2009 | US20090162295 Setting polymers based on polyester acrylates |
| 06/25/2009 | US20090162294 Disposable inhaler |
| 06/25/2009 | US20090162277 Lysophospholipids Solubilized Single-Walled Carbon Nanotubes |
| 06/25/2009 | US20090158696 Process and machine for automated manufacture of gastro-retentive capsules |
| 06/25/2009 | CA2711961A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 06/25/2009 | CA2709561A1 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 06/25/2009 | CA2709268A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | CA2709267A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 06/25/2009 | CA2709266A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | CA2709259A1 Carrier |
| 06/25/2009 | CA2709193A1 User interface improvements for medical devices |
| 06/25/2009 | CA2708443A1 Formulations comprising exine shells |